论文部分内容阅读
目的本文将对肺癌患者给予临床分析,从而探讨血浆中APC基因甲基化检测在早期肺癌诊断的临床意义,为提高肺癌疾病的诊断率从而使患者得到及时治疗以及提高患者生活与生存质量提供可靠临床依据。方法研究组为肺癌患者,对照组一为肺部良性肿瘤患者以及对照组二健康人群分别进行血浆中APC基因甲基化检测,观察并记录三组人群检测结果,进行统计学分析,得出结论。结果研究组肺癌患者体内血浆中APC基因甲基化阳性率为100.00%,明显高于对照组一的3.23%以及对照组二的0.00%,且P<0.05,三组人群对比结果具有统计学意义。结论对患者进行血浆中APC基因甲基化检测,能够根据患者检测结果,较为准确的判断患者是否患有肺癌疾病,使患者及时进行治疗,并制定具有针对性的治疗方案,从而提高患者治疗效果,提高患者生活质量与生存率。
Objective This paper will give a clinical analysis of patients with lung cancer to explore the clinical significance of APC gene methylation detection in the diagnosis of early lung cancer and provide a reliable basis for improving the diagnosis rate of lung cancer patients so that they can be treated promptly and improve their life and quality of life Clinical basis. Methods The research group was lung cancer patients. The control group one was benign lung tumor patients and the control group two healthy subjects were detected APC gene methylation in plasma. The results of three groups were observed and statistically analyzed. The conclusion was reached . Results The positive rate of APC gene methylation in lung cancer patients was 100.00% in the study group, which was significantly higher than 3.23% in the control group one and 0.00% in the control group two, and P <0.05, and the results of the three groups were statistically significant . Conclusion The APC gene methylation in plasma can be used to judge whether patients have lung cancer diseases according to the test results of patients, so that patients can be treated in time and make targeted treatment plans to improve the treatment effect of patients , Improve patient quality of life and survival.